Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Feeder-free system for maintaining pluripotency in embryonic stem cells pioneered

08.01.2004


A newly discovered molecule, nicknamed "BIO", safely maintains human embryonic stem cells in a pluripotent state. Its chemical structure is pictured above. The molecule was originally identified and purified from the purple dye extracted from the mollusk Hexaplex trunculus


Molecule developed from marine mollusk overcomes risks of current methods

Human embryonic stem cell (HESC) lines, or cultures, in the U.S. are not suitable for use in the budding field of regenerative medicine. Their creation using mouse feeder cells, a specialized growth medium, allows scientists to study their basic characteristics, but ultimately the HESCs are too risky to develop in applied medicine because mouse-associated viruses possibly contaminate them.

Now, Rockefeller University researchers in collaboration with two European scientists, have discovered a way around this problem: they’ve devised a system for maintaining existing or new human stem cell lines that excludes the need for troublesome mouse feeder cells.



The findings also have an intriguing underpinning. A marine animal belonging to the gastropod mollusk group is the original source of the compound now in use in the new feeder-free system. The natural molecule from which the new compound has now been synthesized has been harvested for over 2500 years from the creature, known as the red mollusk, as a coveted purple dye.

The identification of the small molecule, pharmacological inhibitor system in stem cells, led by Ali Brivanlou, Ph.D., head of the laboratory of molecular vertebrate embryology and his research associate, Noburo Sato, Ph.D., so far demonstrates superior stability over other methods designed to circumvent the need for mouse feeder cells. Nature Medicine features Brivanlou, Sato and their colleagues’ results in its January 2004 edition. And though still early in the team’s experiments, the stem cells appear to progress and differentiate normally after the compound is removed.

This new system for maintaining pluripotency could be a providential break for basic researchers and clinicians investigating the potential of HESCs, as it is a potential first step in providing an unlimited source of tissue transplant if HESCs’ potential comes to fruition in clinical medicine.

It works like this: a newly purified compound from the purple dye of marine red mollusks - called 6-bromoindirubin-3’-oxime, or by its working acronym, "BIO"- has been shown by Rockefeller scientists to indirectly activate a crucial gene expression mechanism, called the Wnt signaling pathway, in embryonic cells. Wnt signaling occurs when the new compound inhibits a specific protein kinase in embryonic cells, called GSK-3. This enzyme plays an essential role in many normal and disease states from development to neurodegenerative disorders. It is involved in numerous pathways including a highly conserved and important one called the Wnt signaling pathway. When GSK-3 is inactivated, Wnt is active. Chemical inhibition of GSK-3 thus mimics activation of Wnt and this keeps HESCs in an active, undifferentiated state - one of the crucial basic qualities of embryonic stem cells.

"We know precisely how this compound works - that is, on which enzymes and pathways - and that it is very controllable," says Brivanlou. "This knowledge makes the compound useful not only in stem cell research but also, as we are already seeing in the lab, numerous other research areas."

The challenges of HESC applied research are well known, along with the possible rewards. Cultured stem cells must be capable of self-renewal in an undifferentiated state in order to be truly useful.

Brivanlou, a comparative embryologist who studies the basic molecular aspects of very early vertebrate embryonic development, studies embryonic stem cells to determine whether they truly possess the unique qualities with which they are credited. He along with his scientific colleagues already developed a set of research standards for determining what qualifies as an embryonic stem cell, and what remains to be confirmed about them before clinical researchers safely can consider using them in human research. The standards were published in Science in May 2003.

He also revealed, in 2003, a set of genetic markers for human embryonic stem cells, showing that they do not share a majority of their gene expression patterns with mouse embryonic stem cells, and that there is a highly specific genetic definition of embryonic cells that makes them stem cells - in other words, those cells that can give rise to all body cell types. This research was published in Developmental Biology in July 2003.

These accomplishments were deliberate and systematic. The new system hailed from an unanticipated source. Early in 2003, Laurent Meijer, a biochemist from the Roscoff Marine Biology Institute in France, while on sabbatical at Rockefeller University, studying protein kinases involved in neurodegenerative diseases in Dr. Paul Greengard’s laboratory, asked Brivanlou to test a new compound he and his Greek colleague, Leandros Skaltsounis, had derived from naturally- occurring indirubin of Mediterranean mollusks. The two scientists wanted to know if this new compound could act as a potent and selective pharmacological inhibitor of GSK-3, and therefore as potentially useful against neurodegenerative disorders.

"Protein kinases are very promising targets for the discovery of new therapeutic agents," says Meijer. "In particular, pharmacological inhibitors of GSK-3 have great potential for application to treat Alzheimer’s disease and other neurodegenerative disorders, as well as sleep disorders and depression." (There are 520 protein kinases encoded in the human genome.)

Brivanlou and his colleague Alin Vonica, M.D., Ph.D. confirmed that the synthetic compound was able to mimic Wnt activation in the classical model of frog early embryonic development. In the process, Brivanlou also discovered that the compound safely could arrest differentiation of stem cells in frog embryos, while allowing them to continue to self-renew.

Thus far, Brivanlou has applied the BIO compound to frog, mouse and human stem cells, with favorable results.

Lynn Love | Rockefeller University
Further information:
http://www.rockefeller.edu/pubinfo/010504b.php

More articles from Life Sciences:

nachricht Fine organic particles in the atmosphere are more often solid glass beads than liquid oil droplets
21.04.2017 | Max-Planck-Institut für Chemie

nachricht Study overturns seminal research about the developing nervous system
21.04.2017 | University of California - Los Angeles Health Sciences

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

Im Focus: Quantum-physical Model System

Computer-assisted methods aid Heidelberg physicists in reproducing experiment with ultracold atoms

Two researchers at Heidelberg University have developed a model system that enables a better understanding of the processes in a quantum-physical experiment...

Im Focus: Glacier bacteria’s contribution to carbon cycling

Glaciers might seem rather inhospitable environments. However, they are home to a diverse and vibrant microbial community. It’s becoming increasingly clear that they play a bigger role in the carbon cycle than previously thought.

A new study, now published in the journal Nature Geoscience, shows how microbial communities in melting glaciers contribute to the Earth’s carbon cycle, a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

7th International Conference on Crystalline Silicon Photovoltaics in Freiburg on April 3-5, 2017

03.04.2017 | Event News

 
Latest News

New quantum liquid crystals may play role in future of computers

21.04.2017 | Physics and Astronomy

A promising target for kidney fibrosis

21.04.2017 | Health and Medicine

Light rays from a supernova bent by the curvature of space-time around a galaxy

21.04.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>